Antidepressant Options: Venlafaxine in Perspective
- 1 June 1996
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Clinical Psychopharmacology
- Vol. 16 (SUPPLEMENT), 10S-18S
- https://doi.org/10.1097/00004714-199606002-00003
Abstract
Depression is often related to disturbances of norepinephrine and serotonin neurochemical systems within the brain that affect functional neurobehavioral systems. Classes of antidepressant agents have been developed that directly affect proposed brain neurochemical alterations. Many of the differences among antidepressant agents, particularly in safety and tolerability, can be attributed to their differing effects on receptor blockade and neurotransmitter reuptake. The overall goal of antidepressant treatment is complete recovery, and three phases of treatment have been delineated. Because of the recurrent and potentially chronic nature of depression, safety and tolerability of available treatments are especially important. An overview of antidepressant options is presented, with a particular focus on venlafaxine.Keywords
This publication has 35 references indexed in Scilit:
- Sleep research in depressive illness: Clinical implications —a tasting menuBiological Psychiatry, 1995
- Is the Mechanism of Prefrontal Hypofunction in Depression the Same as in Schizophrenia?The British Journal of Psychiatry, 1993
- Transduction of psychosocial stress into the neurobiology of recurrent affective disorderAmerican Journal of Psychiatry, 1992
- Animal models as simulations of depressionTrends in Pharmacological Sciences, 1991
- Reduction of Prefrontal Cortex Glucose Metabolism Common to Three Types of DepressionArchives of General Psychiatry, 1989
- Cerebrospinal Fluid and Urinary Biogenic Amines in Depressed Patients and Healthy ControlsArchives of General Psychiatry, 1988
- A Behavioral Dimension of ConstraintAnnals of the New York Academy of Sciences, 1986
- Consistent evidence for a biological subtype of depression characterized by low CSF monoamine levelsActa Psychiatrica Scandinavica, 1986
- Plasma Norepinephrine Level in Affective DisordersArchives of General Psychiatry, 1985
- CSF monoamine metabolites in melancholiaActa Psychiatrica Scandinavica, 1984